Linee Guida
Linee Guida - Siti che producono linee guida
NGC – National Guideline Clearinghouse – USA (purtroppo non esiste più)
AACE – American Association Clinical Endocrinologists
SIGN – Scottish Intercollegiate Guidelines Network – Scotland
CANADIAN MEDICAL ASSOCIATION – Clinical Practice Guidelines – Canada
NICE – National Institute of Clinical Excellence – UK
NIH – The National Institutes of Health – USA
Linee Guida - Varie
Sousa-Pinto B, et al.
Guidelines International Network: principles for use of artificial intelligence in the health guideline enterprise.
Ann Intern Med 2025, 178: 408-15.
Hopewell S, et al.
CONSORT 2025 Statement. Updated guideline for reporting randomized trials.
JAMA 2025, 333: 1998-2005 (free full text).
Chan AW, et al.
SPIRIT 2025 Statement. Updated guideline for protocols of randomized trials.
JAMA 2025, DOI:10.1001/jama.2025.4486 (free full text).
De Leon DD, et al.
International guidelines for the diagnosis and management of hyperinsulinism.
Hormone Res Pediatr 2024, 97: 279-98 (free full text).
EASL–EASD–EASO.
Clinical practice guidelines on the management of metabolic dysfunction‑associated steatotic liver disease (MASLD): executive summary.
Diabetologia 2024, 67: 2375-92 (free full text).
Gattrell WT, et al.
ACCORD (ACcurate COnsensus Reporting Document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi.
PLoS Med 2024, 21: e1004326 (free full text).
El-Hajj Fuleihan G, Clines GA, Hu MI, et al.
Treatment of hypercalcemia of malignancy in adults: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2023, dgac621 (free full text).
Giustina A, Bouillon R, Dawson-Hughes B, et al.
Vitamin D in the older population: a consensus statement.
Endocrine 2023, 79: 31–44 (free full text).
Società Italiana Talassemie ed Emoglobinopatie.
Le principali complicanze endocrinologiche nelle Emoglobinopatie. Buone Pratiche SITE.
Recenti Progressi in Medicina 2022, 113: 495-554 (free full text).
DeTora LM, Toroser D, Sykes A, et al.
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update.
Ann Intern Med 2022, 175: 1298-304.
Cusi K, et al.
American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings. Co-sponsored by the American Association for the Study of Liver Diseases (AASLD).
Endocr Pract 2022, 28: 528-62. (free full text)
US Preventive Services Task Force.
Statin use for the primary prevention of cardiovascular disease in adults.
JAMA 2022, 328: 746-53 (free full text).
Husebye ES, et al.
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline.
Eur J Endocrinol 2022, 187: G1–21 (free full text).
FitzGerald JD, et al.
2020 American College of Rheumatology guideline for the management of gout.
Arthritis Care Res 2020, 72: 744–60. (free full text)
Couturier J, et al.
Canadian practice guidelines for the treatment of children and adolescents with eating disorders.
J Eating Dis 2020, 8: 4 (free full text).
Bennett BL, et al
Wilderness Medical Society Clinical Practice Guidelines for the Management of Exercise-Associated Hyponatremia: 2019 Update.
Wildern Envirom Med 2020, 31: 50-62 (free full text).
Hiroshi A, et al.
Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine Society.
Endocr J 2019, 66: 581-6 (free full text).
Van Spronsen FJ, van Wegberg AMJ, Ahring K, et al.
Key European guidelines for the diagnosis and management of patients with phenylketonuria.
Lancet Diabetes Endocrinol 2017, 5: 743-56 (free full text).
Roman CJ, Cifu AS, Stein SL.
Management of Acne Vulgaris.
JAMA 2016, 316: 1402-3.
Qaseem A, McLean RM, Starkey M, Forciea MA.
Diagnosis of acute gout: a clinical practice guideline from the American College of Physicians.
Ann Intern Med 2106, doi:10.7326/M16-0569 (free full text).
Qaseem A, Harris RP, Forciea MA.
Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians.
Ann Intern Med 2016, doi:10.7326/M16-0570 (free full text).
European Medicines Agency.
Guide to information on human medicines evaluated by EMA. What the Agency publishes and when.
10 May 2016 EMA/515416/2015 (free full text).
Spasovski G, Vanholder R, Allolio B, et al
Clinical practice guideline on diagnosis and treatment of hyponatraemia.
Eur J Endocrinol 2014, 170: G1–47 (free full text).
Linee Guida - Tiroide
NODULO - CARCINOMA - IPER/IPO - ORBITOPATIA - VARIE - TEST FUNZIONALI
Nodulo
Orloff LA, Noel JE, Stack BC Jr, Russell MD, Angelos P, Baek JH, et al.
Radiofrequency Ablation and Related Ultrasound-Guided Ablation Technologies for Treatment of Benign and Malignant Thyroid Disease: An International Multidisciplinary Consensus Statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association.
Head Neck 2022, 44: 633-60.
Papini E, Monpeyssen H, Frasoldati A, Hegedüs L.
2020 European Thyroid Association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules.
Eur Thyroid J 2020, DOI: 10.1159/000508484 (free full text).
Zhou JQ, et al.
2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules: the C-TIRADS.
Endocrine 2020, 70: 256-79 (free full text).
Pacini F, Basolo F, Bellantone R, Boni G, Cannizzaro MA, De Palma M, Durante C, Elisei R, Fadda G, Frasoldati A, Fugazzola L, Guglielmi R, Lombardi CP, Miccoli P, Papini E, Pellegriti G, Pezzullo L, Pontecorvi A, Salvatori M, Seregni E, Vitti P.
Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies.
J Endocrinol Invest 2018, 41: 849–76 (free full text)
Russ G, Bonnema SJ, Erdogan MF, et al.
European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS.
Eur Thyroid J 2017, 6: 225–37 (free full text).
Paschke R, et al.
European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics.
Eur Thyroid J 2017, 6: 115–29 (free full text).
Papini E, Negro R, Pinchera A, Guglielmi R, Baroli A, Beck-Peccoz P, Garofalo P, Pisoni MP, Zini M, Elisei R and Chiovato L.
Thyroid Nodule and Differentiated Thyroid Cancer Management in Pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice.
J Endocrinol Invest 2010, 33: 579-86.
Carcinoma
Ringel MD, et al.
2025 American Thyroid Association management guidelines for adult patients with differentiated thyroid cancer.
Thyroid 2025, 35: 841-985 (free full text).
Orloff LA, et al.
Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association.
Head & Neck 2022, 44: 633–60.
Howard SR, et al.
Paediatric differentiated thyroid carcinoma: a UK national clinical practice consensus guideline.
Endocr Relat Cancer 2022, 29: G1–33 (free full text).
Mauri G, et al.
European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions.
Eur Thyroid J 2021, 10: 185–97 (free full text).
Bible KC, et al.
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. American Thyroid Association Anaplastic Thyroid Cancer Guidelines Task Force.
Thyroid 2021, 31: 337-86 (free full text).
Fugazzola L, er al.
2019 European Thyroid Association guidelines for the treatment and follow-up of advanced radioiodine-refractory thyroid cancer.
Eur Thyroid J 2019, 8: 227–45 (free full text).
Filetti S, et al.
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol 2019, 30: 1856-83. (free full text).
Pacini F, Basolo F, Bellantone R, Boni G, Cannizzaro MA, De Palma M, Durante C, Elisei R, Fadda G, Frasoldati A, Fugazzola L, Guglielmi R, Lombardi CP, Miccoli P, Papini E, Pellegriti G, Pezzullo L, Pontecorvi A, Salvatori M, Seregni E, Vitti P.
Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies.
J Endocrinol Invest 2018, 41: 849–76.
AIOM.
Linee guida Tumori della tiroide.
2017 (free full text).
Radioactive iodine therapy, molecular imaging and serum biomarkers for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology, Pathology, Biology, Endocrine Surgery and Head and Neck Surgery.
Annal Endocr 2017, 78: 162-75.
The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer.
Thyroid 2015, DOI: 10.1089/thy.2015.0020.
Pacini F, Brianzoni E, Durante C, et al.
Recommendations for post‑surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology.
J Endocrinol Invest 2015, DOI 10.1007/s40618-015-0375-7 (free full text).
Francis GL, Waguespack SG, Bauer AJ et al.
Management guidelines for children with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on pediatric thyroid cancer.
Thyroid 2015, 25: 716-59.
Wells SA Jr, Asa SL, Dralle H, et al.
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. The American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma.
Thyroid 2015, doi:10.1089/thy.2014.0335
Leenhardt L, et al.
2013 European Thyroid Association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer.
Eur Thyroid J 2013, 2: 147–59 (free full text).
Iper-ipotiroidismo
Centanni M, et al.
ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism.
Eur Thyroid J 2025, 14: e250123 (free full text).
van Trotsenburg P, et al.
Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update— An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology.
Thyroid 2021, 31: 387-419 (free full text).
Bednarczuk T, et al.
2021 European Thyroid Association Guidelines for the management of iodine-based contrast media-induced thyroid dysfunction.
Eur Thyroid J 2021, 10: 269–84 (free full text).
Bekkering GE, et al.
Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline.
BMJ 2019, 365: l2006 (free full text).
Persani L, Brabant G, Dattani M, et al.
2018 European Thyroid Association (ETA) guidelines on the diagnosis and management of central hypothyroidism.
Eur Thyroid J 2018, 7: 225-37 (free full text).
Bartalena L, et al.
2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction.
Eur Thyroid J 2018, 7: 55–66 (free full text).
Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA.
2016 American Thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.
Thyroid 2016, 26:1343-421 (free full text).
Satoh T, et al.
2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society.
Endocr J 2016, 63, 1025-64 (free full text).
Biondi B, Bartalena L, Cooper DS, Hegedüs L, Laurberg P, Kahaly GJ.
The 2015 European Thyroid Association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism
Eur Thyroid J 2015, 4: 149-63 (free full text).
Jonklaas J, et al; American Thyroid Association Task Force on Thyroid Hormone Replacement.
Guidelines for the treatment of hypothyroidism.
Thyroid 2014, 24: 1670-751 (free full text).
Lazarus J, et al.
2014 European Thyroid Association guidelines for the management of subclinical hypothyroidism in pregnancy and in children.
Eur Thyroid J 2014, 3: 76–94 (free full text).
Léger J, et al.
European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism.
J Clin Endocrinol Metab 2014, 99: 363–84.
Pearce SHS, et al.
2013 ETA guideline: management of subclinical hypothyroidism.
Eur Thyroid J 2013, 2: 15–28 (free full text).
Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA.
Clinical Practice Guidelines for Hypothyroidism in Adults: Co-sponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association.
Endocr Pract 2012, 11: 1-207.
Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN.
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
Endocrine Practice 2011, 17: 456-520 (free full text).
Orbitopatia
Burch HB, Perros P, Bednarczuk T, et al.
Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association.
Eur Thyroid J 2022, 11: e220189 (free full text) e Thyroid 2022, 32: 1439-70 (free fulll text).
Bartalena L, et al.
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guideline for the medical management of Graves’ orbitopathy.
Eur J Endocrinol 2021, 185: G43-67 (free full text).
Varie
Korevaar TIM, et al.
American Thyroid Association 2026 guidelines for thyroid disease in preconception, pregnancy, and postpartum.
Thyroid 2026, 36: 481-544 (free full text).
Persani L, et al.
2024 European Thyroid Association Guidelines on diagnosis and management of genetic disorders of thyroid hormone transport, metabolism and action.
Eur Thyroid J 2024, 13: e240125 (free full text).
Poppe K, et al.
2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction.
Eur Thyroid J 2020, 9: 281-95 (free full text)
Patel KN, et al.
Executive summary of the American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults.
Ann Surg 2020, 271: 399-410.
Muller I, et al.
2019 European Thyroid Association guidelines on the management of thyroid dysfunction following immune reconstitution therapy
Eur Thyroid J 2019, 8: 173–85 (free full text).
WHO.
Iodine thyroid blocking. Guidelines for use in planning for and responding to radiological and nuclear emergencies.
2017. (free full text)
LeFevre ML, on behalf of the U.S. Preventive Services Task Force.
Screening for thyroid dysfunction: U.S. Preventive Services Task Force Recommendation Statement.
Ann Int Med 2015, 162: 641-50.
Chen AY, et al.
American Thyroid Association statement on optimal surgical management of goiter.
Thyroid 2014, 24: 181-9 (free full text).
Beck-Peccoz P, et al.
2013 European Thyroid Association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors.
Eur Thyroid J 2013, 2: 76-82 (free full text).
Test funzionali
Campi I, et al.
2026 ETA guideline on interference in immunoassay measurements used in assessment of thyroid function.
Eur Thyroid J 2026, 15: ETJ260011 (free full text).
Association for Clinical Biochemistry, British Thyroid Association, British Thyroid Foundation
UK Guidelines for the Use of Thyroid Function Tests.
2006 Full text
Linee Guida - Surreni e Ipertensione Endocrina
Kuhlen M, et al.
European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT group.
Eur J Endocrinol 2025, 193, G113–G126 (free full text).
Adler GK, et al.
Primary Aldosteronism: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2025, 110: 2453–95 (free full text).
Beuschlein F, et al.
European Society of Endocrinology and Endocrine Society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency.
Eur J Endocrinol 2024, 190: G25-51. J Clin Endocrinol Metab 2024, 109: 1657-83 (free full text).
Taïeb D, et al.
Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert consensus statement.
Nature Rev Endocrinol 2024, 20: 168–84 (free full text).
Fassnacht M, Tsagarakis S, Terzolo M, et al.
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.
Eur J Endocrinol 2023, 189: G1–42 (free full text).
Taieb D, et al.
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.
Lancet Diabetes Endocrinol 2023, 11: 345–61.
Tabarin A, Assié G, Barat P, et al.
Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing’s syndrome.
Annal Endocrinol 2022, 83: 119-41.
Fleseriu M, et al.
Consensus on diagnosis and management of Cushing’s disease: a guideline update.
Lancet Diabetes Endocrinol 2021, 9: 847-75 (free full text).
Rossi GP, et al.
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.
Int J Cardiol Hypertens 2020, 5: 100029 (free full text).
Lorenz K, Langer P, Niederle B, et al.
Surgical therapy of adrenal tumors: guidelines from the German Association of Endocrine Surgeons (CAEK).
Langenbecks Arch Surg 2019, 404: 385-401.
Fassnacht M, et al.
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Eur J Endocrinol 2018, 179: G1-46 (free full text).
Phyllis W. Speiser PW, et al.
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2018, doi.org/10.1210/jc.2018-01865 (free full text).
Carey, RM et al.
Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline.
Ann Intern Med 2018, doi:10.7326/M17-3203 (free full text).
Qaseem A, Wilt TJ, Rich R, et al, for the Clinical Guidelines Committee of the American College of Physicians and the Commission on Health of the Public and Science of the American Academy of Family Physicians.
Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.
Ann Intern Med 2017, 166: 430-7 (free full text).
Plouin PF, Amar L, Dekkers OM, et al.
European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.
Eur J Endocrinol 2016, 174: G1–10 (free full text).
Bornstein SR, Allolio B, Arlt W, et al.
Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Med 2016, 101: 364-89 (free full text).
Lenders JWM, et al.
Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2014, 99: 1915-42.
Husebye ES, Allolio B, Arlt W, et al.
Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency.
J Intern Med 2014, 275: 104-15 (free full text).
Linee Guida - Paratiroidi
Khan AA, Bilezikian JP, Brandi ML, et al.
Evaluation and management of hypoparathyroidism: summary statement and guidelines from the second international workshop.
J Bone Min Res 2022, 37: 2568–85 (free full text).
Bilezikian JP, et al.
Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop.
J Bone Min Res 2022, 37: 2293–314. (free full text).
Ovčariček P, e al.
The EANM practice guidelines for parathyroid imaging.
Eur J Nucl Med Molec Imaging 2021, 48: 2801–22 (free full text).
Orloff LA, Wiseman SM, Bernet VJ, et al, for the American Thyroid Association Surgical Affairs Committee Writing Task Force.
American Thyroid Association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults.
Thyroid 2018, 28: 830-41.
Wilhelm SM, et al.
The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism.
JAMA 2016, 151: 959-68.
Brandi ML, et al.
Management of hypoparathyroidism: summary statement and guidelines.
J Clin Endocrinol Metab 2016, 101: 2273-83.
Bollerslev J, et al.
European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults.
Eur J Endocrinol 2015, 173: G1–G20 (free full text).
Marcocci C, Brandi ML, Scillitani A, Corbetta S, Faggiano A, Gianotti L, Migliaccio S, Minisola S.
Italian Society of Endocrinology consensus statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.
J Endocrinol Invest 2015, 38: 577-93.
Rosato L, et al.
Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB).
J Endocrinol Invest 2014, 37: 149–65.
Linee Guida - Osteoporosi e malattie metaboliche dell'osso
Demay MB, et al.
Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2024, 109: 1907-47 (free full text).
Huang CF, et al.
Asia–Pacific consensus for the management of osteoporosis in men.
Osteoporosis Int 2025, 36: 1105–14 (free full text).
Khan AA, et al.
X-linked hypophosphatemia management in adults: an international working group clinical practice guideline.
J Clin Endocrinol Metab 2025, 110: 2353–70 (free full text).
Tanaka Y, et al.
The 2023 guidelines for the management and treatment of glucocorticoid‑induced osteoporosis.
J Bone Min Metab 2024, 42: 143–54 (free full text).
Corrao G, et al.
Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021.
Front Endocrinol 2023, 14: 1137671 (free full text).
Qaseem A, Hicks LA, Etxeandia-Ikobaltzeta I, et al.
Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults: a living clinical guideline from the American College of Physicians.
Ann Intern Med 2023, 176: 224-38..
Camacho PL, et al.
American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2020 update.
Endocr Pract 2020, 26 (suppl 1): 1-46 (free full text).
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D.
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab 2019, 104: 1595-622 (free full text).
Ralston SH, et al.
Diagnosis and management of Paget’s disease of bone in adults: a clinical guideline.
J Bone Min Res 2019: e3657 (free full text).
Kanis JA, et al.
European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Osteopor Int 2019, 30: 3-44.
Pludowski P, et al.
Vitamin D supplementation guidelines.
J Steroid Biochem Mol Biol 2018, 175: 125-35.
Dell R, Greene D.
A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
Osteoporosis Int 2018: 29: 1277-83.
Ketteler M, et al.
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters.
Kidney International 2017, 92: 26–36 (free full text).
Kopecky SL, BauerDC, Gulati M, Nieves JW, Singer AJ, Toth PP, Underberg JA, Wallace TC, Weaver CM.
Lack of evidence linking calcium with or without vitamin D supplementation to cardiovascular disease in generally healthy adults: a clinical guideline from the National Osteoporosis Foundation and the American Society for Preventive Cardiology.
Ann Intern Med 2016, 165: doi:10.7326/M16-1743 (free full text).
Munns CF, et al.
Global consensus recommendations on prevention and management of nutritional rickets.
J Clin Endocrinol Metab 2016, 101: 394-415 (free full text)..
Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES, Finkelstein JS.
Osteoporosis in men: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2012, 97: 1802–22.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM.
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2011, 96: 1911–30.
Linee Guida - Oncologia Endocrina
Baudin E, et al.
European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids.
J Neuroendocrinol 2026, 38: e70174 (free full text).
Del Rivero J, et al.
American Association of Clinical Endocrinology consensus statement on management of multiple endocrine neoplasia type 1.
Endocr Pract 2025, 31: 403-18 (free full text).
Lamarca A, et al.
European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours.
J Neuroendocrinol 2024, 36: e13423 (free full text).
Goudet P, et al.
French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d’étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1.
Ann Endocrinol 2024, 85: 2-19 (free full text).
Kos-Kudła B, et al.
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours.
J Neuroendocrinol 2023, 35: ce13343 (free full text).
Hofland J, et al.
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes.
J Neuroendocrinol 2023, 35: e13318 (free full text).
Panzuto F, et al.
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3.
J Neuroendocrinol 2023, 35: e13306 (free full text).
Eads JR, et al.
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms.
Endocr Relat Cancer 2023, 30: e220206 (free full text).
Rinke A, et al.
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours.
J Neuroendocrinol 2023, 35: e13309 (free full text).
Sorbye H, et al.
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma.
J Neuroendocrinol 2023, 35: e13249 (free full text).
Grozinsky-Glasberg S, et al.
European Neuroendocrine Tumor Society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease.
J Neuroendocrinol 2022, 34: e13146 (free full text).
Dromaine C, et al.
ENETS consensus guidelines for synoptic reporting of radiology studies.
J Neuroendocrinol 2022, DOI: 10.1111/jne.13060 (free full text).
Gallo M, Adinolfi V, Morviducci L, et al.
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
ESMO Open 2021, 6: 100155 (free full text).
Silvestris N, Argentiero A, Natalicchio A, et al.
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
ESMO Open 2021, 6: 100153 (free full text).
Silvestris N, Argentiero A, Beretta G, et al.
Management of metabolic side effects from targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana di Oncologia Medica (AIOM), Associazione Medici Diabetologi (AMD), Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
Crit Rev Oncol Hematol 2020, 154: 103066.
Castinetti F, Albarel F, Archambeaud F, et al.
French Endocrine Society Guidance on endocrine side effects of immunotherapy.
Endocr Relat Cancer 2019, 26: G1-18 (free full text).
Brahmer JR, Lacchetti C, Schneider BJ, et al; National Comprehensive Cancer Network.
Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline.
J Clin Oncol 2018, 36: 1714-68 (free full text).
Higham CE, Olsson-Brown A, Carroll P, et al; Society for Endocrinology Clinical Committee.
Society For Endocrinology endocrine emergency guidance: acute management of the endocrine complications of checkpoint inhibitor therapy.
Endocr Connect 2018, 7: G1-7.
Sklar CA, Antal Z, Chemaitilly W, Cohen LE, Follin C, Meacham LR, Murad MH.
Hypothalamic–Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab 2018, 103: 2761–84 (free full text).
Haanen JBAG, Carbonnel F, Robert C, et al; ESMO Guidelines Committee.
Management of toxicities from immunotherapy: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.
Ann Oncol 2017, 28 (suppl 4): iv119-42 (free full text).
Puzanov I, Diab A, Abdallah K, et al; Society for Immunotherapy of Cancer Toxicity Management Working Group.
Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
J Immunother Cancer 2017, 5: 95 (free full text).
Perren A, Couvelard A, Scoazec JY, et al.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification.
Neuroendocrinology 2017, 105: 196-200.
Oberg K, Couvelard A, Delle Fave G, et al.
ENETS Consensus Guidelines for standard of care in Neuroendocrine Tumours: Biochemical Markers.
Neuroendocrinology 2017, 105: 201-11.
Sundin A, Arnold R, Baudin E, et al.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.
Neuroendocrinology 2017, 105: 212-44.
Partelli S, Bartsch DK, Capdevila J, et al.
ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours.
Neuroendocrinology 2017, 105: 255-65.
Pavel M, Valle J, Eriksson B, et al.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy ‐ Biotherapy and Novel Targeted Agents.
Neuroendocrinology 2017, 105: 266-80.
Garcia-Carbonero R, Rinke A, Valle JW, et al.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms. Systemic Therapy 2: Chemotherapy.
Neuroendocrinology 2017, 105: 281-94.
Hicks RJ, et al.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues.
Neuroendocrinology 2017, 105: 295-309.
Falconi M, Eriksson B, Kaltsas G, et al, and all other Vienna Consensus Conference participants.
ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors.
Neuroendocrinology 2016, 103 (2): 153-171.
Niederle B, Pape UF, Costa F, et al, and all other Vienna Consensus Conference participants.
ENETS Consensus Guidelines update for neuroendocrine neoplasm of the jejunum and ileum.
Neuroendocrinology 2016, 103:125-138.
Delle Fave G, Kwekkeboom DJ, Van Cutsem E, et al, and all other Vienna Consensus Conference participants.
ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms.
Neuroendocrinology 2016, 103 (2): 119-124.
Pavel M, O'Toole D, Costa F, Capdevila J, et al, and all other Vienna Consensus Conference participants.
ENETS Consensus Guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site.
Neuroendocrinology 2016, 103:172-185.
Associazione Italiana Oncologia Medica.
Linee guida Neoplasie Neuroendocrine (in condivisione con It.a.net.)
2016 (free full text).
AIOM - SIE – SIGO.
Raccomandazioni su oncofertilità (free full text).
AIOM.
Linee guida neoplasie dell’utero: endometrio e cervice.
2015 (free full text).
Pavel M, Grossman A, Arnold R, et al.
ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors.
Neuroendocrinology 2010, 91: 326–32.
Kianmanesh R, Ruszniewski P, Rindi G, et al.
ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors.
Neuroendocrinology 2010, 91: 333–40.
Kos-Kudła B, O’Toole D, Falconi M, et al.
ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors.
Neuroendocrinology 2010, 91: 341–50.
Linee Guida - Obesità
WHO guideline on the integrated management of obesity in adolescents. 2026 (free full text).
Doody P, et al.
National and international clinical guidelines for the management of obesity in adults: a systematic review.
Obes Rev 2026, DOI: https://doi.org/10.1111/obr.70163 (free full text).
Qaseem A, et al.
Pharmacologic treatments with lifestyle modifications in nonpregnant adults with overweight or obesity in outpatient settings: a living clinical guideline from the American College of Physicians (April 2026).
Ann Intern Med 2026, 179: 1177-85 (free full text).
Corrado RL, et al.
Adult overweight and obesity management: updates from the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guidelines.
Ann Intern Med 2026, 179: 1296-311 (free full text).
Lambadiari V, et al.
Clinical guidelines for the diagnosis and management of generalized and partial lipodystrophies: a position statement endorsed by the Hellenic Endocrine Society.
Endocr Pract 2026, 32: 1008-16.
Lapolla A, et al.
Medical nutrition therapy in physiological pregnancy and in pregnancy complicated by obesity and/or diabetes: SID-AMD recommendations.
Acta Diabetol 2026, 63: 349–68 (free full text).
Stephens JW, et al.
Diabetes management in people undergoing metabolic-bariatric surgery: a guideline from the Joint British Diabetes Societies for Inpatient Care (JBDS-IP) Group.
Diabet Med 2026, 43: e70281 (free full text).
World Health Organization.
WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults.
2025: https://app.magicapp.org/#/guideline/LrRxrL (free full text).
Nadolsky K, et al.
American Association of Clinical Endocrinology consensus statement: algorithm for the evaluation and treatment of adults with obesity/adiposity-based chronic disease — 2025 update.
Endocr Pract 2025, 31: 1351-94 (free full text).
Hazlehurst J, et al.
Society for Endocrinology guidelines for the diagnosis and management of post-bariatric hypoglycaemia.
Endocr Connect 2024, 13: e230285 (free full text).
Muscogiuri G, El Ghoch M, Colao A, et al. Obesity Management Task Force (OMTF) of the European Association for the Study of Obesity (EASO).
European guidelines for obesity management in adults with a very low-calorie ketogenic diet: a systematic review and meta-analysis.
Obes Facts 2021, 14: 222-45 (free full text).
Oppert JM, et al.
Exercise training in the management of overweight and obesity in adults: Synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group.
Obesity Rev 2021, 22 (S4): e13273 (free full text).
O’Kane M, et al.
British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery—2020 update.
Obesity Rev 2020, 21: e13087(free full text).
Wharton S, et al.
Obesity in adults: a clinical practice guideline.
CMAJ 2020, 192: E875-91 (free full text).
Pasquali R, et al.
European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity.
Eur J Endocrinol 2020, 182: G1–32 (free full text).
Simon A, et al.
Guidelines for the management of pregnant women with obesity: A systematic review.
Obesity Rev 2020, 21: e12972 (free full text).
Mechanick JI, et al.
Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists.
Endocr Pract 2019, DOI:10.4158/GL-2019-0406 (free full text).
Durrer Schutz D, et al.
European practical and patient-centred guidelines for adult obesity management in primary care.
Obes Facts 2019, 12: 40–66 (free full text).
Piercy KL, et al.
The physical activity guidelines for Americans.
JAMA 2018, 320: 2020-8 (free full text).
Styne DM, Arslanian SA, Connor EL, et al.
Pediatric obesity—assessment, treatment, and prevention: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2017, 102: 709–57 (free full text).
Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, Mungai L, Oral EA, Patni N, Rother K, von Schnurbein J, Sorkina E, Stanley T, Vigouroux C, Wabitsch M, Williams R, Yorifuji T.
The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline.
J Clin Endocrinol Metab 2016, DOI: 10.1210/jc.2016-2466.
Garvey WT, Mechanick JI, ECNU, Brett EM, et al
American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for comprehensive medical care of patients with obesity – executive summary.
Endocr Pract 2016, DOI:10.4158/EP161365.GL (free full text).
Canadian Task Force on Preventive Health Care.
Recommendations for growth monitoring, and prevention and management of overweight and obesity in children and youth in primary care.
CMAJ 2015, 187: 411-21 (free full text).
Apovian CM, et al.
Pharmacological management of obesity: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2015, doi: 10.1210/jc.2014-3415.
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society.
Circulation published online November 12, 2013. DOI: 10.1161/01.cir.0000437739.71477.ee (free full text).
Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C.
Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: An Endocrine Society Clinical Practice Guideline
J Clin Endocrinol Metab 2010, 95: 4823–43.
Linee Guida - Ipofisi
Fleseriu M, et al.
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.
Nature Rev Endocrinol 2025, 21: 638–55 (free full text).
Raverot G, et al.
Revised European Society of Endocrinology clinical practice guideline for the management of aggressive pituitary tumours and pituitary carcinomas.
Eur J Endocrinol 2025, 192, G1–34 (free full text).
Cunya T, et al.
Diagnosis and management of children and adult craniopharyngiomas: a French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes consensus statement.
Annal Endocrinol 2025, 86: 101631 (free full text).
Korbonits M, et al.
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: part 1, general recommendations.
Nature Rev Endocrinol 2024, 20: 278–89 (free full text).
Korbonits M, et al.
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: part 2, specific diseases.
Nature Rev Endocrinol 2024, 20: 290–309 (free full text).
Gan HW, et al.
National UK guidelines for the management of paediatric craniopharyngioma.
Lancet Diabetes Endocrinol 2023, 11: 694–706.
Fleseriu M, et al.
Consensus on diagnosis and management of Cushing’s disease: a guideline update.
Lancet Diabetes Endocrinol 2021, 9: 847-75 (free full text).
Luger A, et al.
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy.
Eur J Endocrinol 2021,185: G1-33 (free full text).
Fleseriu M, et al.
A Pituitary Society update to acromegaly management guidelines.
Pituitary 2021, 24: 1–13 (free full text).
Yuen KCJ, et al.
American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. 2019 AACE growth hormone task force.
Endocr Pract 2019, 25: 1191-232 (free full text).
Baldeweg SE, Ball S, Brooke A, et al, on behalf of the Society for Endocrinology Clinical Committee.
Inpatient management of cranial diabetes insipidus (free full text)
Endocr Connect 2018, 7: G8–G11.
Persani L, Brabant G, Dattani M, et al.
2018 European Thyroid Association (ETA) guidelines on the diagnosis and management of central hypothyroidism.
Eur Thyroid J 2018, 7: 225-37 (free full text).
Fleseriu M, Hashim IA, Karavitaki N, et al.
Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2016, 101: 3888-921.
Gordon CM, Ackerman KE, Berga SL, et al.
Functional hypothalamic amenorrhea: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2017, 102: 1413-39 (free full text).
Aghi MK, Chen CC, Fleseriu M, Newman SA, Lucas JW, Kuo JS, Barkhoudarian G, Farrell CJ, Sheehan J, Ziu M, Dunn IF.
Congress of Neurological Surgeons systematic review and evidence-based guidelines on the management of patients with nonfunctioning pituitary adenomas: executive summary.
Neurosurgery 2016, 79: 521–3 (free full text).
Chen CC, Carter BS, Wang R, Patel KS, Hess C, Bodach ME, Tumialan LM, Oyesiku NM, Patil CG, Litvack Z, Zada G, Aghi MK.
Congress of Neurological Surgeons systematic review and evidence-based guideline on preoperative imaging assessment of patients with suspected nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E524–6 (free full text).
Fleseriu M, Bodach ME, Tumialan LM, Bonert V, Oyesiku NM, Patil CG, Litvack Z, Aghi MK, Zada G.
Congress of Neurological Surgeons systematic review and evidence-based guideline for pretreatment endocrine evaluation of patients with nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E527–9 (free full text).
Newman SA, Turbin RE, Bodach ME, Tumialan LM, Oyesiku NM, Litvack Z, Zada G, Patil CG, Aghi MK.
Congress of Neurological Surgeons systematic review and evidence-based guidelines on pretreatment ophthalmology evaluation in patients with suspected nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E530–2 (free full text).
Lucas JW, Bodach ME, Tumialan LM, Oyesiku NM, Patil CG, Litvack Z, Aghi MK, Zada G.
Congress of Neurological Surgeons systematic review and evidence-based guidelines on primary management of patients with nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E533–5 (free full text).
Kuo JS, Barkhoudarian G, Farrell CJ, Bodach ME, Tumialan LM, Oyesiku NM, Litvack Z, Zada G, Patil CG, Aghi MK.
Congress of Neurological Surgeons systematic review and evidence-based guideline on surgical techniques and technologies for the management of patients with nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E536–8 (free full text).
Sheehan J, Lee CC, Bodach ME, Tumialan LM, Oyesiku NM, Patil CG, Litvack Z, Zada G, Aghi MK.
Congress of Neurological Surgeons systematic review and evidence-based guideline for the management of patients with residual or recurrent nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E539–40 (free full text).
Ziu M, Dunn IF, Hess C, Fleseriu M, Bodach ME, Tumialan LM, Oyesiku NM, Patel KS, Wang R, Carter BS, Chen JY, Chen CC, Patil CG, Litvack Z, Zada G, Aghi MK.
Congress of Neurological Surgeons systematic review and evidence-based guideline on posttreatment follow-up evaluation of patients with nonfunctioning pituitary adenomas.
Neurosurgery 2016, 79: E541–3 (free full text).
Baroni MG, et al.
SID/SIE guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.
J Endocrinol Invest 2016, 39: 235-55.
Giustina A, et al.
Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline.
J Endocrinol Invest 2014, 37: 1017–30 (free full text).
Beck-Peccoz P, et al.
2013 European Thyroid Association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors.
Eur Thyroid J 2013, 2: 76-82 (free full text).
Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML.
Pituitary incidentaloma: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2011, 96: 894–904.
Melmed S, Casanueva F, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JAH.
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2011, 96: 273–88.
Linee Guida - Iperlipidemie e sindrome metabolica
Arnold MA, et al.
A synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline for lipid management for cardiovascular disease risk reduction.
Ann Intern Med 2026, 179: 1460-72 (free full text).
Patel SB, et al.
American Association of Clinical Endocrinology clinical practice guideline on pharmacologic management of adults with dyslipidemia.
Endocr Pract 2025, 31: 236-62 (free full text).
Newman CB, et al.
Lipid management in patients with endocrine disorders: an Endocrine Society clinical practice guideline
J Clin Endocrinol Metab 2020, 105: dgaa674 (free full text).
Rosenzweig JL, et al.
Primary prevention of ASCVD and T2DM in patients at metabolic risk: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab 2019, 104: 3939–85 (free full text).
Arnett DK, et al.
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease.
J Am Coll Cardiol 2019, DOI: 10.1016/j.jacc.2019.03.010.
Notizie in evidenza dal mondo AME
-
Pubblicato l'aggiornamento della LG ISS su Terapia dell’obesità resistente al trattamento comportamentale nella popolazione adulta con comorbilità
Terapia dell’obesità resistente al trattamento comportamentale nella popolazione adulta con...
-
Novità di Endowiki (pagina costantemente aggiornata)
Negli ultimi 24 mesi sono stati pubblicati questi nuovi capitoli:
- Obesità adolescenti, arriva la prima Linea Guida sulla gestione terapeutica
-
Pubblicata la LG ISS su Terapia del sovrappeso e dell’obesità negli adolescenti
Terapia del sovrappeso e dell’obesità resistenti al trattamento comportamentale negli adolescenti...
AIFA informa

Ultime notizie da AIFA:
04/07/2026: aggiornamento delle note 39 e 74
12/08/2024: Due nuove uscite da AIFA: Libretto "NON SI TROVA!" - Carenze e indisponibilità di farmaci e "Carenze e indisponibilità di farmaci - DATI E BUONE PRATICHE 01/2024"
Formazione continua

ENDOWIKI
Per tutti gli operatori di endocrinologia: lo stato dell'arte su clinica e terapia.
Uno strumento semplice e fruibile da tutti coloro che intendono essere sempre aggiornati, promosso dai migliori del settore.
BLOG

BLOG
Cari Soci, il nuovo blog dell’editoria AME è partito!
Potrete scrivere i vostri commenti o fare domande sulle pubblicazioni editoriali AME più interessanti o che affrontino temi dibattuti.


